Compare CVR & ADXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CVR | ADXN |
|---|---|---|
| Founded | 1920 | 2002 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.4M | 8.6M |
| IPO Year | 1995 | 2019 |
| Metric | CVR | ADXN |
|---|---|---|
| Price | $9.90 | $5.89 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 1.6K | ★ 1.9K |
| Earning Date | 05-12-2026 | 04-30-2026 |
| Dividend Yield | ★ 1.06% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $27,890,260.00 | N/A |
| Revenue This Year | N/A | $86.57 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 3.35 | N/A |
| 52 Week Low | $8.50 | $5.41 |
| 52 Week High | $15.00 | $12.05 |
| Indicator | CVR | ADXN |
|---|---|---|
| Relative Strength Index (RSI) | 46.14 | 47.00 |
| Support Level | $9.42 | $5.53 |
| Resistance Level | $11.10 | $7.37 |
| Average True Range (ATR) | 0.29 | 0.20 |
| MACD | -0.01 | 0.01 |
| Stochastic Oscillator | 38.27 | 33.53 |
Chicago Rivet & Machine Co is in the fastener industry in North America. The company operates in two segments namely fasteners and assembly equipment. Its fastener segment consists of the manufacture and sale of rivets, cold-formed fasteners, parts, and screw machine products. The assembly equipment segment consists mainly of the manufacture of automatic rivet setting machines, automatic assembly equipment, and parts and tools for such machines. The majority of revenue is from the fastener segment.
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.